Natera to Scale AI Foundation Models in Precision Medicine with NVIDIA — Neutral

NTRA   Business Wire — January 12, 2026

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA testing and precision medicine, today announced a new collaboration with NVIDIA to accelerate the development of Natera's multimodal AI foundation model platform and expand applications across precision medicine. Under the collaboration, Natera will integrate its unique longitudinal and multi-time point in vivo datasets and proprietary machine learning models with NVIDIA's high-performance computing pla.

image for news Natera to Scale AI Foundation Models in Precision Medicine with NVIDIA

Tech's Mixed Analyst Views: AKAM Double Upgrade, CRWD & SNOW Downgrades — Neutral

CRWD   Schwab Network — January 12, 2026

It's a mixed picture for analysts in the tech space to start the trading week. Diane King Hall explains why Morgan Stanley issued a double upgrade for Akamai Technologies (AKAM).

image for news Tech's Mixed Analyst Views: AKAM Double Upgrade, CRWD & SNOW Downgrades

Meta announced on Monday that it has appointed former Trump advisor Dina Powell McCormick as president and vice chairman of the company. Meta said Powell McCormick will be a member of the company's management team and will help guide Meta's overall strategy and execution.

image for news Meta hires former Trump advisor Dina Powell McCormick as president and vice chair

Paramount Plans Proxy Fight to Push Hostile Warner Bid — Negative

PSKY  WBD   WSJ — January 12, 2026

The company also said Monday it filed a lawsuit seeking more information on Warner's deal with Netflix

image for news Paramount Plans Proxy Fight to Push Hostile Warner Bid

Medicus Pharma (NASDAQ:MDCX) announced that it will present new Phase 1 clinical data on its long-acting gonadotropin-releasing hormone (GnRH) antagonist Teverelix at the American Association of Clinical Endocrinology (AACE) Annual Meeting in April 2026. The company said its abstract, titled “Evaluation of Teverelix, a Long-Acting GnRH Antagonist: Pharmacokinetics, Pharmacodynamics, Bone Turnover and Safety in Two Phase 1 Studies in Healthy Female Volunteers,” has been accepted for e-Poster presentation at the meeting, which will be held April 22 to 24 in Las Vegas.

image for news Medicus Pharma advances Teverelix program, set to present Phase 1 data at AACE Annual Meeting

LOS ANGELES, Jan. 12, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Jayud Global Logistics Limited (“Jayud” or “the Company”) (NASDAQ: JYD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 21, 2023 and April 30, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before January 20, 2026.

image for news JYD Investors Have Opportunity to Lead Jayud Global Logistics Limited Securities Fraud Lawsuit with the Schall Law Firm

Ferrari N.V. is upgraded to Buy as valuation compresses and key risks abate, offering renewed upside. Governance stability is reinforced by a renewed shareholder pact, while lifestyle and Tailor Made car initiatives support profit growth. EV execution risk has eased thanks to regulatory flexibility and RACE's luxury positioning, while the 2026 FIA rule reset represents a clean starting point after a weak 2025 on-track season.

image for news Ferrari: De-Risked Setup, Reset Year Ahead, Valuation Back In Play (Rating Upgrade)

LOS ANGELES, Jan. 12, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against StubHub Holdings, Inc. (“StubHub” or “the Company”) (NYSE: STUB) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to its initial public offering (“IPO”) conducted on September 17, 2025, are encouraged to contact the firm before January 23, 2026.

image for news STUB Investors Have Opportunity to Lead StubHub Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm

AbbVie Down 3% in a Month: Why Holding the Stock Still Makes Sense — Positive

ABBV   Zacks Investment Research — January 12, 2026

ABBV stock falls 3% in a month amid takeover rumor denials, but Skyrizi and Rinvoq momentum and a deep pipeline support staying invested.

image for news AbbVie Down 3% in a Month: Why Holding the Stock Still Makes Sense

4 Best Gold & Silver Stocks to Buy As Prices Hit New Highs — Positive

AEM  HL  PAAS  RGLD   Zacks Investment Research — January 12, 2026

Gold and silver touch fresh highs in 2026. Here are four stocks poised to benefit from the precious metals rally.

image for news 4 Best Gold & Silver Stocks to Buy As Prices Hit New Highs

J.M. Smucker's Pet Food Sales Soft: Is Demand Normalizing Yet? — Positive

SJM   Zacks Investment Research — January 12, 2026

SJM's Q2 pet food sales drop 7% as dog snacks lag, but pricing gains and margin expansion suggest demand is stabilizing.

image for news J.M. Smucker's Pet Food Sales Soft: Is Demand Normalizing Yet?

Recent Price Trend in Amer Sports, Inc. (AS) is Your Friend, Here's Why — Positive

AS   Zacks Investment Research — January 12, 2026

Amer Sports, Inc. (AS) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

image for news Recent Price Trend in Amer Sports, Inc. (AS) is Your Friend, Here's Why

Here's Why 'Trend' Investors Would Love Betting on Northrim (NRIM) — Positive

NRIM   Zacks Investment Research — January 12, 2026

Northrim (NRIM) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

image for news Here's Why 'Trend' Investors Would Love Betting on Northrim (NRIM)

Despite Fast-paced Momentum, Jabil (JBL) Is Still a Bargain Stock — Positive

JBL   Zacks Investment Research — January 12, 2026

Jabil (JBL) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

image for news Despite Fast-paced Momentum, Jabil (JBL) Is Still a Bargain Stock

Why Fast-paced Mover American Eagle (AEO) Is a Great Choice for Value Investors — Positive

AEO   Zacks Investment Research — January 12, 2026

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, American Eagle (AEO) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

image for news Why Fast-paced Mover American Eagle (AEO) Is a Great Choice for Value Investors

Why Investors Need to Take Advantage of These 2 Transportation Stocks Now — Positive

CPA  UPS   Zacks Investment Research — January 12, 2026

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

image for news Why Investors Need to Take Advantage of These 2 Transportation Stocks Now

Why Investors Need to Take Advantage of These 2 Finance Stocks Now — Positive

ACRE  SPGI   Zacks Investment Research — January 12, 2026

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

image for news Why Investors Need to Take Advantage of These 2 Finance Stocks Now

The US stock market has been a bit soft in the early hours of Monday, but we remain in consolidation at the moment.

image for news NASDAQ Index, S&P 500 and Dow Jones Forecasts – US Indices Pull Back to Start Week

What META's 1.2 GW Deal Means for OKLO's Ohio Nuclear Build — Positive

OKLO   Zacks Investment Research — January 12, 2026

META's prepayment deal boosts OKLO's 1.2 GW Ohio nuclear project, tying early funding to long-term data center power demand.

image for news What META's 1.2 GW Deal Means for OKLO's Ohio Nuclear Build

LOS ANGELES, Jan. 12, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Perrigo Company plc (“Perrigo” or “the Company”) (NYSE: PRGO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 27, 2025 and November 4, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before January 16, 2026.

image for news PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit with the Schall Law Firm